// App-Quantinova.ai

3352 : Enhanced Fibrinolysis by Proteolysed Coagulation Factor Xa Is Inhibited by Rivaroxaban

Researchers

Presenter

  • Kimberley Talbot

Principal Investigators

  • Tyler W Smith

  • Agnes Y.Y. Lee

  • Edward L.G. Pryzdial

Medical Centers

  • Division of Hematology, University of British Columbia, Vancouver, BC, Canada

  • Canadian Blood Services, Research and Development Department, and University of British Columbia, Centre for Blood Research, Department of Pathology and Laboratory Medicine, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Deep vein thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • folitixorin calcium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved